Serum levels of androgens and prostate-specific antigen in endometriosis
dc.contributor.author | Evsen, M. S. | |
dc.contributor.author | Sak, M. E. | |
dc.contributor.author | Soydinc, H. E. | |
dc.contributor.author | Guven, S. | |
dc.contributor.author | Basaranoglu, S. | |
dc.contributor.author | Hatipoglu, N. K. | |
dc.contributor.author | Evliyaoglu, O. | |
dc.date.accessioned | 2024-04-24T17:38:03Z | |
dc.date.available | 2024-04-24T17:38:03Z | |
dc.date.issued | 2014 | |
dc.department | Dicle Üniversitesi | en_US |
dc.description.abstract | Objective: The aim of the present study was to evaluate the levels of serum androgens and prostate-specific antigen (PSA) levels in patients with endometriosis. Materials and Methods: Patients with Stage III/IV(advanced stage) endometriosis were compared to controls with respect to basal serum levels of total testosterone (T), free testosterone (fT), androstenedion (A), dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulphate (DHEA-S), and PSA in the early follicular phase of menstrual cycle for this prospective case control study. Results: Level of T, IT, A, DHEA, and DHEA-S were higher in patients with endometriosis when compared to control subjects, but the difference was not statistically significant. The mean PSA level was 0.0074 +/- 0.0120 ng/ml in patients with endometriosis and 0.0059 +/- 0.0056 ng/ml in control group and there was no statistically significant difference between groups (p = 0.58). Conclusion: Serum basal androgens and PSA levels are higher in endometriosis group with respect to control but the differences are not statistically significant. | en_US |
dc.identifier.endpage | 435 | en_US |
dc.identifier.issn | 0390-6663 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 25134292 | |
dc.identifier.scopus | 2-s2.0-84905368810 | |
dc.identifier.scopusquality | Q4 | |
dc.identifier.startpage | 432 | en_US |
dc.identifier.uri | https://hdl.handle.net/11468/21302 | |
dc.identifier.volume | 41 | en_US |
dc.identifier.wos | WOS:000340081300015 | |
dc.identifier.wosquality | Q4 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | en_US |
dc.publisher | I R O G Canada, Inc | en_US |
dc.relation.ispartof | Clinical and Experimental Obstetrics & Gynecology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Endometriosis | en_US |
dc.subject | Androgens | en_US |
dc.subject | Prostate-Specific Antigen | en_US |
dc.title | Serum levels of androgens and prostate-specific antigen in endometriosis | en_US |
dc.title | Serum levels of androgens and prostate-specific antigen in endometriosis | |
dc.type | Article | en_US |